This startup develops AI-powered gait analysis devices that diagnose walking abnormalities and track patient progress. Their non-invasive sensors provide real-time movement monitoring to help clinicians develop personalized treatment plans for gait disorders.
Funding
Funding not disclosed
Founders
Product
Problem
Diagnosing gait disorders relies on qualitative, time-consuming visual observation, making it difficult to quantify abnormalities and track treatment response effectively. This can lead to suboptimal treatment plans and prolonged recovery times for patients.
Solution
bEarly TechnoVations offers paceB, an AI-integrated gait analysis device that provides a quantitative assessment of gait abnormalities. The device substitutes for traditional visual examination, enabling in-depth screening and quantified prognostication. By comparing gait analysis data pre- and post-treatment, healthcare professionals can optimize medication and therapy, leading to improved patient outcomes. The system generates AI-integrated reports that provide technical interpretations for doctors and simplified explanations for patients.
Target Audience
The primary users are doctors, therapists, and healthcare professionals involved in diagnosing and treating gait disorders, as well as patients seeking a more quantitative and understandable assessment of their condition.
Features
- Quantified gait disorder screening, replacing qualitative visual observation
- Comparison of pre- and post-treatment gait analysis for quantified prognostication
- AI-integrated reports with technical interpretations for doctors
- Simplified report interpretations for patients
- User-centric software application with functional UI/UX design
- Capability to create user profiles and perform in-depth gait analysis